Tacrolimus: all 596 studies that test it
Page 4 of 6. Open to participants first (54), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetics of Tacrolimus in ChildrenCompletedNCT03347357Phase 4
- Envarsus XR® in Adolescent Renal Transplant RecipientsActive, not recruitingNCT03266393Phase 4
- Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant RecipientCompletedNCT03256864Phase 4
- Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital TraumaWithdrawnNCT03240822Phase 1
- The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized VitiligoStatus unknownNCT03234673Phase 1
- Tacrolimus in Children With Henoch-Schönlein Purpura NephritisCompletedNCT03222687Phase 4
- Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorStatus unknownNCT03171831Phase 4
- Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine CorneaStatus unknownNCT03105466Not applicable
- Drug/Drug Interactions With F901318WithdrawnNCT03095547Phase 1
- Drug Interaction Study of Apixaban With Cyclosporine and TacrolimusCompletedNCT03083782Phase 1
- Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney TransplantationCompletedNCT03076151Phase 4
- Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for VitiligoCompletedNCT03047733Not applicable
- A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing ToxicityCompletedNCT03032783Phase 2
- AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney TransplantationStatus unknownNCT03005236Phase 4
- Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical StudyCompletedNCT02970630Phase 2
- A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive RegimenTerminatedNCT02963103Phase 4
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.Active, not recruitingNCT02936505Not applicable
- De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised StudyWithdrawnNCT02909335Phase 3
- Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After ConversionStatus unknownNCT02882113Phase 4
- Omental Islet TransplantCompletedNCT02821026Phase 1/2
- Incidence of Non Adherence to Treatment With Once-daily Formulation of TacrolimusStatus unknownNCT02805842Phase 3
- Ocular Penetration of Topical Tacrolimus Eye DropsStatus unknownNCT02794610Not applicable
- Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen PlanusCompletedNCT02744378Phase 2
- Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy AdultsCompletedNCT02743247Phase 1
- Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant RecipientsCompletedNCT02706678Phase 4
- Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
- Comparative Effectiveness Trial in the Treatment of Pediatric Plaque MorpheaWithdrawnNCT02680717Phase 1
- Allo HSCT Using RIC for Hematological DiseasesCompletedNCT02661035Phase 2
- Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling DonorCompletedNCT02660684Phase 4
- A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsTerminatedNCT02653196Early Phase 1
- Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus NephritisCompletedNCT02630628Phase 3
- Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic ReceptorsCompletedNCT02608606Not applicable
- To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)CompletedNCT02601703Phase 3
- Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMDWithdrawnNCT02563782Phase 2
- Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell LymphomaWithdrawnNCT02548468Phase 1
- Once-a-day Tacrolimus Conversion Study: The OneTAC TrialStatus unknownNCT02545972Phase 4
- Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal TransplantationCompletedNCT02540395Not applicable
- Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisWithdrawnNCT02528877Phase 1
- Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant PatientsCompletedNCT02500212Phase 4
- The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant RecipientsStatus unknownNCT02496494Phase 4
- Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITACCompletedNCT02466997Phase 3
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus NephritisCompletedNCT02457221Phase 3
- Topical Tacrolimus in Vernal KeratoconjunctivitisStatus unknownNCT02456025Phase 4
- Allogeneic Stem Cell Transplantation for Patients With Multiple MyelomaWithdrawnNCT02447055Early Phase 1
- Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant PatientsCompletedNCT02432833Phase 4
- A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in IndiaCompletedNCT02432053Phase 4
- Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male VolunteeersCompletedNCT02341274Phase 1
- Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant PatientsStatus unknownNCT02337036Not applicable
- Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic PolymorphismStatus unknownNCT02311010Phase 4
- A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus CapsuleTerminatedNCT02268201Phase 4
- Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal TransplantStatus unknownNCT02251691Phase 4
- Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve GastrectomyCompletedNCT02221583Phase 4
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceCompletedNCT02167958Phase 1
- Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney TransplantationCompletedNCT02161237Phase 4
- Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)Status unknownNCT02154854Phase 4
- Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT02122081Phase 1
- MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney TransplantationStatus unknownNCT02091973Not applicable
- Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant PatientsCompletedNCT02077556Phase 4
- Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver TransplantationStatus unknownNCT02064777Phase 4
- A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant RecipientsCompletedNCT02034747Phase 4
- Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic DermatitisCompletedNCT02004860Phase 3
- Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&SirolimusCompletedNCT01958190Phase 4
- Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous NephropathyCompletedNCT01955187Phase 3
- Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant RecipientsStatus unknownNCT01927588Phase 4
- Pharmacokinetic Studies of Tacrolimus in Transplant PatientsCompletedNCT01889758Phase 4
- A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant SubjectsCompletedNCT01882322Phase 4
- Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsCompletedNCT01850979Phase 4
- Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus ControlTerminatedNCT01841008Phase 2/3
- A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAFCompletedNCT01839929Phase 4
- An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisCompletedNCT01828879Phase 4
- Myfortic in High MELD Liver TransplantationWithdrawnNCT01807767Not applicable
- Prograf-Advagraf Cross Over Conversion StudyCompletedNCT01797341Phase 3
- Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host DiseaseCompletedNCT01788501Phase 2/3
- An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisCompletedNCT01782729Phase 4
- A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant RecipientsCompletedNCT01780844Phase 2
- A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic SyndromeCompletedNCT01763580Phase 4
- Efficacy and Safety Study of Tacrobell to Treat Rheumatoid ArthritisCompletedNCT01746680Phase 4
- Preventive Treatment of Tacrolimus Ointment in Children With Atopic DermatitisCompletedNCT01745159Phase 4
- Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)Status unknownNCT01744470Phase 4
- A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal RecipientsCompletedNCT01742676Phase 4
- Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the TransplantationCompletedNCT01742624Phase 4
- Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular RiskCompletedNCT01702207Phase 4
- The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant RecipientsStatus unknownNCT01699360Phase 4
- Generic Tacrolimus in the Elderly - Prograf® vs Tacni®CompletedNCT01698541Phase 4
- A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male VolunteersCompletedNCT01681134Phase 1
- Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis CongenitaActive, not recruitingNCT01659606Phase 2
- Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney TransplantationCompletedNCT01640743Not applicable
- A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of TimeCompletedNCT01614665Phase 2
- A Clinical Trial to Assess the Efficacy and Safety of the Conversion to EverolimusStatus unknownNCT01608412Phase 4
- Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic DermatitisCompletedNCT01591070Phase 4
- TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus PerfusionTerminatedNCT01564095Phase 2/3
- Tacrolimus Ointment in Oral Lichen PlanusTerminatedNCT01544842Not applicable
- Drug Interaction Study of Isavuconazole and TacrolimusCompletedNCT01535547Phase 1
- A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)CompletedNCT01511003Phase 4
- Kidney Allograft Dysfunction Without Reversible CausesWithdrawnNCT01492894Phase 4
- Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell TransplantsTerminatedNCT01488253Phase 2
- A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and TacrolimusCompletedNCT01479881Phase 1
- The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental GlomerulosclerosisTerminatedNCT01451489Not applicable
- AADAPT - Analysis of Advagraf Dose Adaptation Post TransplantationCompletedNCT01435291Phase 4